Back

EVOQUE TTVR: clinical evidence shaping patient selection

20 February 2026 (12:36 - 12:47)
Organised by: Logo
Congress Presentation Part of: Evolving atrioventricular valve therapies: updated guidelines and innovations for mitral regurgitation and tricuspid regurgitation patients Intervention EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Maria Isabel Koerber

Cologne University Hospital - Heart Center, Cologne (Germany)

6 More presentations in this session

Presentation thumbnail
Introduction learning objectives
Professor J. Hausleiter (Munich, DE)
Presentation thumbnail
The updated ESC/EACTS-VHD guidelines - transforming patient care
Associate Professor F. Praz (Bern, CH)
Slides
Presentation thumbnail
Lessons from treating mitral regurgitation with mitral TEER
Doctor R. Smith
Slides
Presentation thumbnail
Lessons from treating tricuspid regurgitation with tricuspid TEER
Doctor M. Wild (Freiburg, DE)
Slides
Presentation thumbnail
EVOQUE TTVR: expanding its role
Doctor M. Adam (Hamburg, DE)
Slides

Access the full session

Session thumbnail
Evolving atrioventricular valve therapies: updated guidelines and innovations for mitral regurgitation and tricuspid regurgitation patients
Video

The Event

Event poster

EAPCI Summit 2026

20 February 2026 12:36 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources